181 related articles for article (PubMed ID: 29331953)
1. Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
BMJ Support Palliat Care; 2018 Jun; 8(2):117-128. PubMed ID: 29331953
[TBL] [Abstract][Full Text] [Related]
2. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
3. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS; Page AJ; Chi Y
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD003870. PubMed ID: 35679121
[TBL] [Abstract][Full Text] [Related]
4. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003870. PubMed ID: 25723351
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of oxycodone in the management of cancer pain.
King SJ; Reid C; Forbes K; Hanks G
Palliat Med; 2011 Jul; 25(5):454-70. PubMed ID: 21708852
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.
Zecca E; Brunelli C; Bracchi P; Biancofiore G; De Sangro C; Bortolussi R; Montanari L; Maltoni M; Moro C; Colonna U; Finco G; Roy MT; Ferrari V; Alabiso O; Rosti G; Kaasa S; Caraceni A
J Pain Symptom Manage; 2016 Dec; 52(6):783-794.e6. PubMed ID: 27742577
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review.
Schmidt-Hansen M; Taubert M; Bromham N; Hilgart JS; Arnold S
BMJ Support Palliat Care; 2016 Sep; 6(3):292-306. PubMed ID: 26669324
[TBL] [Abstract][Full Text] [Related]
8. Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation.
Zhou J; Wang Y; Jiang G
PLoS One; 2020; 15(4):e0231763. PubMed ID: 32302346
[TBL] [Abstract][Full Text] [Related]
9. Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis.
Guo KK; Deng CQ; Lu GJ; Zhao GL
BMC Anesthesiol; 2018 Sep; 18(1):132. PubMed ID: 30249205
[TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
11. Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.
Morgan CL; Jenkins-Jones S; Currie C; Baxter G
Adv Ther; 2019 Jun; 36(6):1412-1425. PubMed ID: 30963513
[TBL] [Abstract][Full Text] [Related]
12. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.
Reid CM; Martin RM; Sterne JA; Davies AN; Hanks GW
Arch Intern Med; 2006 Apr; 166(8):837-43. PubMed ID: 16636208
[TBL] [Abstract][Full Text] [Related]
13. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
Ho HS
Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
15. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
[TBL] [Abstract][Full Text] [Related]
16. Oxycodone for Cancer Pain in Adult Patients.
Schmidt-Hansen M; Bennett MI; Hilgart J
JAMA; 2015 Sep 22-29; 314(12):1282-3. PubMed ID: 26393852
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
Ikenberg R; Hertel N; Moore RA; Obradovic M; Baxter G; Conway P; Liedgens H
J Med Econ; 2012; 15(4):724-36. PubMed ID: 22364286
[TBL] [Abstract][Full Text] [Related]
18. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
[TBL] [Abstract][Full Text] [Related]
19. A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study.
Liang J; Chen L; Yang S; Zhang H; Li L; Chen Z; Zhang S; Xian H; Tang Y; Deng Y; Feng W
Ann Palliat Med; 2021 Jan; 10(1):88-96. PubMed ID: 33474955
[TBL] [Abstract][Full Text] [Related]
20. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
